Skip to content
10-K

Annual Report

INTELLIA THERAPEUTICS, INC. NTLA

0001193125-26-076550

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 13, 2026 118.13M sh
Shares Diluted FY 2025 · Dec 31, 2025 108.38M sh
Shares Diluted FY 2025 · Dec 31, 2024 98.85M sh
Shares Diluted FY 2025 · Dec 31, 2023 88.77M sh
Capex FY 2025 · Dec 31, 2025 $1.13M
Capex FY 2025 · Dec 31, 2024 $5.78M
Capex FY 2025 · Dec 31, 2023 $13.99M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$394.74M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$348.88M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$394.09M
Cash And Equivalents FY 2025 · Dec 31, 2025 $155.46M
Cash And Equivalents FY 2025 · Dec 31, 2024 $189.18M
Cash And Equivalents FY 2025 · Dec 31, 2023 $226.75M
Stockholders Equity FY 2025 · Dec 31, 2025 $671.39M
Stockholders Equity FY 2025 · Dec 31, 2024 $871.96M
Stockholders Equity FY 2025 · Dec 31, 2023 $1.05B
Stockholders Equity FY 2025 · Dec 31, 2022 $1.24B
Current Liabilities FY 2025 · Dec 31, 2025 $103.88M
Current Liabilities FY 2025 · Dec 31, 2024 $110.85M
Total Liabilities FY 2025 · Dec 31, 2025 $170.73M
Total Liabilities FY 2025 · Dec 31, 2024 $319.06M
Current Assets FY 2025 · Dec 31, 2025 $527.71M
Current Assets FY 2025 · Dec 31, 2024 $639.86M
Total Assets FY 2025 · Dec 31, 2025 $842.13M
Total Assets FY 2025 · Dec 31, 2024 $1.19B
Eps Diluted FY 2025 · Dec 31, 2025 −$3.81
Eps Diluted FY 2025 · Dec 31, 2024 −$5.25
Eps Diluted FY 2025 · Dec 31, 2023 −$5.42
Eps Basic FY 2025 · Dec 31, 2025 −$3.81
Eps Basic FY 2025 · Dec 31, 2024 −$5.25
Eps Basic FY 2025 · Dec 31, 2023 −$5.42
Sga Expense FY 2025 · Dec 31, 2025 $119.8M
Sga Expense FY 2025 · Dec 31, 2024 $125.83M
Sga Expense FY 2025 · Dec 31, 2023 $116.5M
Rd Expense FY 2025 · Dec 31, 2025 $388.86M
Rd Expense FY 2025 · Dec 31, 2024 $466.31M
Rd Expense FY 2025 · Dec 31, 2023 $435.07M
Net Income FY 2025 · Dec 31, 2025 −$412.69M
Net Income FY 2025 · Dec 31, 2024 −$519.02M
Net Income FY 2025 · Dec 31, 2023 −$481.19M
Operating Income FY 2025 · Dec 31, 2025 −$440.99M
Operating Income FY 2025 · Dec 31, 2024 −$534.26M
Operating Income FY 2025 · Dec 31, 2023 −$515.29M
Revenue FY 2025 · Dec 31, 2025 $67.67M
Revenue FY 2025 · Dec 31, 2024 $57.88M
Revenue FY 2025 · Dec 31, 2023 $36.28M